abbvie glp 1 AbbVie's enters weight loss drug market with a bet on an phase GLP-1 alternative AbbVie licenses obesity drug from

Name: abbvie glp 1 AbbVie's enters weight loss drug market with a bet on an phase GLP-1 alternative AbbVie licenses obesity drug from
Brand: live-language.pl
SKU: 87415046643
Price: 25.47 USD
Availability: InStock
Rating: 4.1215 (27 reviews)

SKU: 87415046643

4.1

USD25.47 USD50.47

Pay in 4 interest-free payments of $6.37 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

AbbVie licenses obesity drug from Gubra, entering weight loss field AbbVie Joins Obesity Treatment Market With Up to $2.2B Licensing Deal How GLP 1 medications are transforming diabetes and weight loss treatment Vital Record GLP 1s Linked to Systemic Clinical Risk Reduction in Hidradenitis Suppurativa MedPage Today abbvie glp 1 receptor agonist weight management diabetes treatments Triple Agonism Based Therapies for Obesity Current Cardiovascular Risk Reports

Store: live-language.pl · Domain: live-language.pl

Description

Acknowledgements The authors acknowledge the support from the European Commission (H2020-MSCA-IF-79212)